Closing the evidence gap in older adults with extensive-stage small-cell lung cancer: a CGA-guided, risk-adapted treatment framework
Therapeutic Advances in Medical Oncology
Published online on July 13, 2026
Abstract
Therapeutic Advances in Medical Oncology, Volume 18, January-December 2026.
Therapeutic decision-making for older adults, operationally defined in this review as patients aged ⩾65 years, with extensive-stage small-cell lung cancer (ES-SCLC) remains clinically challenging, complicated by heterogeneous decline in physiological ...
Therapeutic decision-making for older adults, operationally defined in this review as patients aged ⩾65 years, with extensive-stage small-cell lung cancer (ES-SCLC) remains clinically challenging, complicated by heterogeneous decline in physiological ...